Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: A longitudinal study
- 1 May 2010
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 31 (5) , 758-764
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairmentNeurobiology of Aging, 2007
- Usefulness of Longitudinal Measurements of β-Amyloid1–42 in Cerebrospinal Fluid of Patients with Various Cognitive and Neurologic DisordersClinical Chemistry, 2006
- Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairmentNeurobiology of Aging, 2006
- Brain volume loss in MCI predicts dementiaNeurology, 2006
- Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer diseaseNeurology, 2005
- CSF markers for incipient Alzheimer's diseaseThe Lancet Neurology, 2003
- Rates of global and regional cerebral atrophy in AD and frontotemporal dementiaNeurology, 2001
- Correlation between rates of brain atrophy and cognitive decline in ADNeurology, 1999
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- “Mini-mental state”Journal of Psychiatric Research, 1975